Alpha Teknova (TKNO) Amortization of Deferred Charges (2021 - 2026)
Alpha Teknova (TKNO) posted quarterly Amortization of Deferred Charges of $47000.0 for Q1 2026, down 45.35% year-over-year from $86000.0 in Q1 2025, and little changed quarter-over-quarter from $47000.0 in Q4 2025.
Alpha Teknova (TKNO) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Amortization of Deferred Charges for 6 consecutive years, with $47000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization of Deferred Charges fell 45.35% year-over-year to $47000.0; the TTM figure through Mar 2026 stood at $181000.0 (down 54.29% YoY), while the FY2025 annual figure was $220000.0, down 44.16% from the prior year.
- Amortization of Deferred Charges steadied at $47000.0 in Q1 2026 per TKNO's latest filing, from $47000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $205000.0 in Q3 2023 and bottomed at $43000.0 in Q2 2025.
- Historically, Amortization of Deferred Charges has averaged $84529.4 across 5 years, with a median of $84000.0 in 2024.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges surged 241.67% — and 2025, when it sank 58.65%.
- Alpha Teknova's Amortization of Deferred Charges stood at $119000.0 in 2022, then tumbled by 30.25% to $83000.0 in 2023, then rose by 24.1% to $103000.0 in 2024, then tumbled by 54.37% to $47000.0 in 2025, then changed by 0.0% to $47000.0 in 2026.
- Business Quant data shows TKNO's Amortization of Deferred Charges at $47000.0 in Q1 2026, $47000.0 in Q4 2025, and $44000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48,000.00 |
| Jun 30, 2026 | 48,000.00 |
| Mar 31, 2026 | 47,000.00 |
| Mar 31, 2026 | 47,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Sep 30, 2025 | 44,000.00 |
| Sep 30, 2025 | 44,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Sep 30, 2024 | 103,000.00 |
| Sep 30, 2024 | 103,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Mar 31, 2024 | 84,000.00 |